An editorial from the AAFP suggests that the US statin guidelines are too stringent and not cost-efficient when compared to other countries:
Although the American guideline saved a few more lives than the New Zealand guideline, it did so at great cost. If the least expensive statins cost $200 per year, the drug costs associated with the American guideline would be $198,000 to prevent one death, compared with $108,000 for the New Zealand guideline. This does not include the additional costs associated with subsequent office visits and other expenses for monitoring or managing side effects of treatment, all of which make the American guideline even more expensive.
Related posts:
- “Uniquely American tort laws” contributing to health costs
- Should we pay American doctors less money?
- Cutting health care costs means reducing utilization
- Rising health care costs and the tax preference for employer-based health insurance
- When compassion meets progress in American health care
- Medicare and cutting health care costs
- What is responsible for high health care costs?
KevinMD.com on Facebook
 
Follow on Twitter  
Subscribe








{ 1 comment }
Guidelines are the result of political processes, not science.
Comments on this entry are closed.